SMTL ID : 2oc0.1

Structure of NS3 complexed with a ketoamide inhibitor SCh491762

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.30 Å

Oligo State

hetero-2-2-mer

Ligands

2 x ZN: ZINC ION(Non-covalent)

ZN.1: 4 residues within 4Å: Chain A: C.108, T.109, C.110, C.156 4 PLIP interactions: 3 interactions with chain A, 1 Ligand-Water interactions Metal complexes: A:C.108, A:C.110, A:C.156, H2O.1 ZN.4: 4 residues within 4Å: Chain C: C.108, T.109, C.110, C.156 4 PLIP interactions: 3 interactions with chain C, 1 Ligand-Water interactions Metal complexes: C:C.108, C:C.110, C:C.156, H2O.6

1 x BME: BETA-MERCAPTOETHANOL(Non-functional Binders)

BME.2: 3 residues within 4Å: Chain A: C.27, I.28, T.49 No protein-ligand interaction detected (PLIP)

1 x HU1: TERT-BUTYL {(1S)-2-[(1R,2S,5S)-2-({[(1S)-3-AMINO-1-(CYCLOBUTYLMETHYL)-2,3-DIOXOPROPYL]AMINO}CARBONYL)-6,6-DIMETHYL-3-AZABICYCLO[3.1.0]HEX-3-YL]-1-CYCLOHEXYL-2-OXOETHYL}CARBAMATE(Covalent)

HU1.3: 16 residues within 4Å: Chain A: Q.52, T.53, F.54, H.68, I.143, L.146, K.147, G.148, S.149, S.150, F.165, R.166, A.167, A.168, C.170, D.179 18 PLIP interactions: 18 interactions with chain A Hydrophobic interactions: A:H.68, A:I.143, A:I.143, A:L.146, A:K.147, A:F.165, A:F.165, A:A.167, A:A.168, A:D.179 Hydrogen bonds: A:T.53, A:G.148, A:S.150, A:S.150, A:R.166, A:A.168, A:A.168 Water bridges: A:C.170

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Prongay, A.J. et al., Discovery of the HCV NS3/4A protease inhibitor (1R,5S)-N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3- [2(S)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]- 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(S)-carboxamide (Sch 503034) II. Key steps in structure-based optimization. J.Med.Chem. (2007)

Release Date

2007-07-31

Peptides

Hepatitis C Virus: AC
Hepatitis C virus: BD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

C
C

B
B

D
D

Hepatitis C Virus

Hepatitis C virus

Related Entries With Identical Sequence